Active Solicitation · DEPARTMENT OF HEALTH AND HUMAN SERVICES

    PURITY SPECIFICATIONS, STORAGE AND DISTRIBUTION FOR MEDICATIONS DEVELOPMENT

    Sol. 75N98026R00136Special NoticeBethesda, MD
    Open · 9d remaining
    DAYS TO CLOSE
    9
    closes Aug 15, 2026
    POSTED
    Jul 30, 2026
    Publication date
    NAICS CODE
    541715
    Primary industry classification
    PSC CODE
    AN22
    Product & service classification

    AI Summary

    The National Institute on Drug Abuse is seeking capability statements from small businesses to act as a centralized repository for compounds. The project involves inventorying, analyzing, and storing compounds under both non-GMP and GMP conditions, requiring DEA Research Registration for controlled substances.

    Contract details

    Solicitation No.
    75N98026R00136
    Notice Type
    Special Notice
    Posted Date
    July 30, 2026
    Response Deadline
    August 15, 2026
    NAICS Code
    541715AI guide
    PSC / Class Code
    AN22
    Primary Contact
    Polina Klimenkova
    State
    MD
    ZIP Code
    20892
    AI Product/Service
    service

    Description

    TITLE: Purity Specifications, Storage and Distribution for Medications Development

    This is a Sources Sought notice. THIS IS NOT A REQUEST FOR PROPOSALS, ABSTRACTS, OR QUOTATIONS. This notice is for information and planning purposes only and does not commit the Government to any contractual agreement. The Government does not intend to award a contract based on responses under this announcement nor otherwise pay for preparing any information sent for the Government's use. Any proprietary information should be so marked.

    PROJECT REQUIREMENTS

    The National Institute on Drug Abuse (NIDA) seeks capability statements from small businesses having the in-house capability to act as a centralized repository for compounds (i.e., chemical and biological) from domestic and international investigators, commercial sources, and pharmaceutical companies. Specifically, the project requires the following tasks:

    The major goal of this project is to provide NIDA and other NIH Institutes with a holding site which has the capability to inventory, analyze and store compounds, prepared under both non-GMP (Good Manufacturing Practices) and GMP conditions, in amounts ranging from milligram quantities to several kilograms. In accordance with the Controlled Substances Act of 1970, DEA Research Registration for Schedules II to V and potentially Schedule I controlled substances will be required.

    Please see the attachment for more details.

    Key dates

    1. July 30, 2026Posted Date
    2. August 15, 2026Proposals / Responses Due

    AI search tags

    Frequently asked questions

    PURITY SPECIFICATIONS, STORAGE AND DISTRIBUTION FOR MEDICATIONS DEVELOPMENT is a federal acquisition solicitation issued by DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.

    SamSearch Platform

    Stop searching. Start winning.

    AI-powered intelligence for the right opportunities, the right leads, and the right time.